Regeneron Pharmaceuticals, Inc. (0R2M)
Market Closed
11 Apr, 15:30
$
551. 69
+7.6
+1.4%
$
- Market Cap
24.52 P/E Ratio
0% Div Yield
399 Volume
42.79 Eps
$ 544.09
Previous Close Day Range
534.07 560.26
Year Range
528.76 1,210.92
Earnings results expected in 17 days
Want to track 0R2M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| REGN Regeneron Pharmaceuticals, Inc. 30 Apr 2025 (17 Days) | | - Cons. EPS | - EPS |
| REGN Regeneron Pharmaceuticals, Inc. 31 Jan 2025 | | 11.38 Cons. EPS | 12.07 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 31 Oct 2024 | | 11.69 Cons. EPS | 12.46 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 1 Aug 2024 | | 10.61 Cons. EPS | 11.56 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 2 May 2024 | | 10.09 Cons. EPS | 9.55 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 2 Feb 2024 | | 10.73 Cons. EPS | 11.86 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 2 Nov 2023 | | 10.72 Cons. EPS | 11.59 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2016 | | 2.71 Cons. EPS | 3.13 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 4 Aug 2016 | | 2.65 Cons. EPS | 2.82 EPS |
| REGN Regeneron Pharmaceuticals, Inc. 5 May 2016 | | 2.58 Cons. EPS | 2.57 EPS |
2025 © Marketlog. All Rights Reserved.
